peptide,mhc_binding,expression_tpm,evasion_features,evasion_susceptibility,evasion_mechanisms,evasion_resistance_score
YLQPRTFLL,"{'HLA-A*02:01': {'binding_score': 0.8, 'strong_binder': True}}",8.5,"{'conservation_score': 0.6507974930262844, 'mutation_frequency': 0.3222222222222222, 'mhc_binding_strength': 0.8, 'expression_level': 0.85, 'tissue_specificity': 0.30697276545091007, 'immunodominance': 0.68, 'structural_accessibility': 0.6845001366235011}",0.1171643282348107,"{'mutation_escape': {'susceptibility': 0.11252080780264168, 'resistance_strategies': ['conserved_regions', 'broad_targeting']}, 'antigen_loss': {'susceptibility': 0.29682213092765825, 'resistance_strategies': ['conserved_epitopes', 'multi_epitope_targeting']}, 'mhc_downregulation': {'susceptibility': 0.8, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}}",0.446693594210276
KIADYNYKL,"{'HLA-A*02:01': {'binding_score': 0.7, 'weak_binder': True}}",12.3,"{'conservation_score': 0.42623743872503794, 'mutation_frequency': 0.3222222222222222, 'mhc_binding_strength': 0.7, 'expression_level': 1, 'tissue_specificity': 0.48950077195500136, 'immunodominance': 0.861, 'structural_accessibility': 0.37192008777858343}",0.39967545521071635,"{'mutation_escape': {'susceptibility': 0.1848790475219322, 'resistance_strategies': ['conserved_regions', 'broad_targeting']}, 'antigen_loss': {'susceptibility': 0.5737625612749621, 'resistance_strategies': ['conserved_epitopes', 'multi_epitope_targeting']}, 'mhc_downregulation': {'susceptibility': 0.7, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}}",0.33215537938786993
SLYNTVATL,"{'HLA-A*02:01': {'binding_score': 0.9, 'strong_binder': True}}",15.2,"{'conservation_score': 0.3637326146463805, 'mutation_frequency': 0.3222222222222222, 'mhc_binding_strength': 0.9, 'expression_level': 1, 'tissue_specificity': 0.5313662193436643, 'immunodominance': 1, 'structural_accessibility': 0.3490075959488154}",0.45857813213449977,"{'mutation_escape': {'susceptibility': 0.20501949083616625, 'resistance_strategies': ['conserved_regions', 'broad_targeting']}, 'antigen_loss': {'susceptibility': 0.6362673853536195, 'resistance_strategies': ['conserved_epitopes', 'multi_epitope_targeting']}, 'mhc_downregulation': {'susceptibility': 0.9, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}}",0.34542549190326816
GILGFVFTL,"{'HLA-A*02:01': {'binding_score': 0.6, 'weak_binder': True}}",6.8,"{'conservation_score': 0.6745229138435597, 'mutation_frequency': 0.3333333333333333, 'mhc_binding_strength': 0.6, 'expression_level': 0.6799999999999999, 'tissue_specificity': 0.3166682590259255, 'immunodominance': 0.408, 'structural_accessibility': 0.48406675327686766}",0.052523375550962204,"{'mutation_escape': {'susceptibility': 0.10849236205214677, 'resistance_strategies': ['conserved_regions', 'broad_targeting']}, 'antigen_loss': {'susceptibility': 0.2213244185863794, 'resistance_strategies': ['conserved_epitopes', 'multi_epitope_targeting']}, 'mhc_downregulation': {'susceptibility': 0.6, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}}",0.44340115130319485
